PREVALENCE OF HELICOBACTER PYLORI IN OBESE PATIENT

Mohammed J. Altaee, Bilal Mohammed, Ahmed S. Jasim, Hasanin Abdulkadhm

Abstract

Background: Helicobacter pylori is a widely recognized pathogen that exhibits a high prevalence among the global population. The infection caused by H. pylori poses significant health risks due to its association with various gastrointestinal disorders, including gastric ulcers, duodenal ulcers, chronic gastritis, and gastric carcinoma. The regulation of gastric hormones, such as ghrelin and leptin, plays a crucial role in energy homeostasis. Ghrelin, secreted by P/D1 cells in the stomach during periods of hunger, stimulates appetite and promotes food consumption. Conversely, leptin, released by P cells in the stomach and adipocytes after food intake, reduces appetite and fosters a sense of fullness. Individuals infected with H. pylori tend to have lower plasma levels of both ghrelin and leptin compared to those who are not infected. Consequently, the reduced serum leptin levels can delay the sensation of satiety during meals, leading to increased energy intake and a potential development of obesity. Aim: Our study has been proposed and structured to achieve the below objectives: Prevalence of H. pylori associated with overweight. Presence or absence of some clinical signs among patient. Prevalence of infection among age group. Methods: Blood seem were collected from 30 person during the period from February to April 2023 and both gender were participate in this study with age ranging from 20-50 years old.Blood tests were used to measure the antibodies against H pylori. The sample were collected and small amount of it applied in to well In the test line area, anti-human IgG is rendered immobile. Following its addition to the device's specimen well, the specimen reacts with the test's H. pylori antigen-coated particles. This mixture interacts with the immobilized anti-human IgG and migrates chromatographically over the course of the test. A colored line will show up in the test line region, signifying a positive result, if the samples contain H. pylori antibodies. A colored line indicating a negative result won't show up in this area if the specimen is devoid of H. pylori antibodies. To act as a methodical. Result: Our study shows that Middle age group were the highest percentage among other age group (35 %). In another hand the overweight patient suffering from H. pylori infection constitutes about 36.7 %.
Keywords: Helicobacter Pylori, Obese Patient, Infection.

References

Abdullahi, M., Annibale, B., Capoccia, D., Tari, R., Lahner, E., Osborn, J., and Severi, C. (2008) The eradication of Helicobacter pylori is affected by body mass index (BMI), Obesity surgery, 18:1450-1454.

Abreo, A., Gebretsadik, T., Stone, C.A. and Hartert, T.V. (2018) The impact of modifiable risk factor reduction on childhood asthma development. Clinical and Translational Medicine, 7:1-12.

Al-Zubaidi, A. M., Alzobydi, A. H., Alsareii, S. A., Al-Shahrani, A., Alzaman, N. & Kassim, S. (2018) Body mass index and Helicobacter pylori among obese and non-obese patients in Najran, Saudi Arabia: a case-control study. International Journal of Environmental Research and Public Health, 15(11):2586.

Bado, A., Levasseur, S., Attoub, S., Kermorgant, S., Laigneau, J. P., Bortoluzzi, M. N. and Lewin, M. J. (1998) The stomach is a source of leptin. Nature, 394(6695):790-793.

Bae, H. J., Kim, J. S., Kim, B. W. & Nam, Y. J. (2018) Concomitant or sequential therapy as the first-line therapy for eradication of Helicobacter pylori infection in Korea: A systematic review and metaanalysis. The Korean Journal of Gastroenterology, 71(1):31-37.

Blaser, M. J. & Atherton, J. C. (2004) Helicobacter pylori persistence: Biology and disease. The Journal of Clinical Investigation, 113(3):321-333.

Chang, W. L., Yeh, Y. C. & Sheu, B.S. (2018) The impacts of H. pylori virulence factors on the development of gastroduodenal diseases. Journal of Biomedical Science, 25:1-9.

Chooi, Y. C., Ding, C., & Magkos, F. (2019) The epidemiology of obesity. Metabolism, 92:6-10.

Chu, N. F., Wang, S. C., Chang, H. Y. & Wu, D. M. (2010) Medical services utilization and expenditure of obesity-related disorders in Taiwanese adults. Value in Health, 13(6):829-836.

Cornejo-Pareja, I., Martín-Núñez, G. M., Roca-Rodríguez, M. M., Cardona, F., Coin-Aragüez, L., Sánchez-Alcoholado, L., Ji, J. & Yang, H. (2020) Using probiotics as supplementation for Helicobacter pylori antibiotic therapy. International journal of molecular sciences, 21(3): 1136.‏

Khedmat, H., Karbasi-Afshar, R., Agah, S. & Taheri, S. (2013) Helicobacter pylori Infection in the general population: A Middle Eastern perspective. Caspian Journal of Internal Medicine, 4(4):745.‏

Khedmat, H., Karbasi-Afshar, R., Agah, S. & Taheri, S. (2013) Helicobacter pylori Infection in the general population: A Middle Eastern perspective. Caspian Journal of Internal Medicine, 4(4):745.‏

Hussein, N. R. (2010) Helicobacter pylori and gastric cancer in the Middle East: A new enigma?. World journal of Gastroenterology: WJG, 16(26):3226.‏

Debowski, A. W., Walton, S. M., Chua, E. G., Tay, A. C. Y., Liao, T., Lamichhane, B. & Benghezal, M. (2017) Helicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection. PLoS pathogens, 13(6):e1006464.‏

Brasil-Costa, I., Souza, C. D. O., Monteiro, L. C. R., Santos, M. E. S., Oliveira, E. H. C. D. & Burbano, R. M. R. (2022) H. pylori infection and virulence factors cagA and vacA (s and m regions) in gastric adenocarcinoma from Pará State, Brazil. Pathogens, 11(4):414.‏

Khedmat, H., Karbasi-Afshar, R., Agah, S. & Taheri, S. (2013) Helicobacter pylori Infection in the general population: A Middle Eastern perspective. Caspian Journal of Internal Medicine, 4(4):745.‏

Hainer, V., Zamrazilová, H., Kunešová, M., Bendlova, B., & Aldhoon-Hainerova, I. (2015). Obesity and infection: reciprocal causality. Physiological research, 64.‏

Carabotti, M., Lahner, E., Porowska, B., Colacci, E., Trentino, P., Annibale, B., Severi, C. (2014) Are clinical features able to predict Helicobacter pylori gastritis patterns? Evidence from tertiary centers. Internal and emergency medicine, 9:841-845.‏

Dhurandhar, N. V., Bailey, D., & Thomas, D. (2015) Interaction of obesity and infections. Obesity Reviews, 16(12):1017-1029.‏

Siddiqui, B., Kamran, M., Tikmani, S. S., Azmat, R., Mushtaq, Z., Zafar, S. B., Abbas, Z. (2021). Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study. SAGE Open Medicine, 9: 20503121211025421.‏

Pan, S. Y., Litscher, G., Gao, S. H., Zhou, S. F., Yu, Z. L., Chen, H. Q. & Ko, K. M. (2014) Historical perspective of traditional indigenous medical practices: The current renaissance and conservation of herbal resources. Evidence‐ Based Complementary and Alternative Medicine, 2014(1):525340.‏

Blaser, M. J. & Atherton, J. C. (2004) Helicobacter pylori persistence: Biology and disease. The Journal of Clinical Investigation, 113(3):321-333.‏

Refbacks

  • There are currently no refbacks.